ARCA Biopharma Inc ABIO
$20.75 $0.34 (1.67%) 1D
Last Updated: Nov 22, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is ARCA Biopharma Inc Stock Halal?
Shariah Compliance Analysis of ABIO Stock
Germany Health Care Nano Cap No. As of September 2026, ARCA Biopharma Inc (ABIO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. ARCA Biopharma Inc does not pass Musaffa's business and financial screening criteria.
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The company is headquartered in Westminster, Colorado and currently employs 4 full-time employees. The company went IPO on 2000-07-21. The firm's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties that is developing for the treatment of atrial fibrillation in patients with heart failure. Its Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), is a protein therapeutic in clinical development as a potential treatment for patients with COVID-19. The company is also evaluating options for development of its assets, including partnering and other strategic options.
ABIO Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, ARCA Biopharma Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
ARCA Biopharma Inc (ABIO) Chart
Financial Metrics & Statements of ARCA Biopharma Inc (ABIO)
FAQ's for ARCA Biopharma Inc (ABIO)
- As of September 2026, ARCA Biopharma Inc ABIO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes ARCA Biopharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in ARCA Biopharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of ARCA Biopharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of ARCA Biopharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of ARCA Biopharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for ARCA Biopharma Inc (ABIO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
